Enhancing patients’ access to high-quality and affordable medicinal products across the European Union while preserving the financial sustainability of healthcare systems should be the overarching aim of the current revision of the general pharmaceutical legislation. Civil society organisations representing healthcare providers, patients, healthcare professionals and payers have joined forces to outline how the revision of the general pharmaceutical legislation should:

  1. Foster affordability to improve access to high-quality medicinal products,
  2. Improve the assessment and evidence requirement of medicinal products’ effectiveness and safety, and
  3. Ensure a sufficient supply of medicinal products and combat shortages.

We call on the European Commission to include the considerations that have been put forward in this joint statement in the revision of the general pharmaceutical legislation.

joint statement on the revision of the pharmaceutical legislation signatories
Get involved !

Get involved !

Sign up here to receive our updates on European health policy and invitations to our events.

Subscribe now

You have Successfully Subscribed!